WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 1 fonti

VIVAZEN® Commends the Drug Enforcement Administration’s Decision to Schedule Synthetic 7-Hydroxymitragynine (7-OH) and Three Related Drugs

VIVAZEN® Commends the Drug Enforcement Administration’s Decision to Schedule Synthetic 7-Hydroxymitragynine (7-OH) and Three Related Drugs

Raccontata damorningstar.com

Timeline cronologica

  1. mercoledì 1 luglio 2026·morningstar.com

    VIVAZEN® Commends the Drug Enforcement Administration’s Decision to Schedule Synthetic 7-Hydroxymitragynine (7-OH) and Three Related Drugs

    VIVAZEN® Commends the Drug Enforcement Administration’s Decision to Schedule Synthetic 7-Hydroxymitragynine (7-OH) and Three Related Drugs

  2. giovedì 2 luglio 2026·morningstar.com

    BBHW Supports DEA Scheduling of 7-OH and Three Related Drugs is an Important Step to Take Dangerous, Synthetic Products Off of the Market

    BBHW Supports DEA Scheduling of 7-OH and Three Related Drugs is an Important Step to Take Dangerous, Synthetic Products Off of the Market

  3. giovedì 2 luglio 2026·morningstar.com

    Statement from Shatterproof on DEA's Temporary Scheduling of 7-Hydroxymitragynine (7-OH) and Related Substances

    Statement from Shatterproof on DEA's Temporary Scheduling of 7-Hydroxymitragynine (7-OH) and Related Substances